EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Retractable Technologies's Enterprise Value is $-13.97 Mil.
Retractable Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-7.41 Mil. Therefore, Retractable Technologies's EV-to-FCF for today is 1.88.
The historical rank and industry rank for Retractable Technologies's EV-to-FCF or its related term are showing as below:
RVP'
s EV-to-FCF Range Over the Past 10 Years
Min: -4999.95 Med: -4.64 Max: 20400.23
Current: 1.88
During the past 13 years, the highest EV-to-FCF of Retractable Technologies was 20400.23. The lowest was -4999.95. And the median was -4.64.
RVP's EV-to-FCF is ranked better than 96.63% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 23.355
vs RVP: 1.88
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Retractable Technologies's PE Ratio (TTM) for today is calculated as:
Retractable Technologies's share price for today is $0.685.
Retractable Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.210.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Retractable Technologies EV-to-FCF Related Terms
Retractable Technologies EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Retractable Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Retractable Technologies EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Retractable Technologies's EV-to-FCF falls into.
Retractable Technologies's current Enterprise Value is $-13.97 Mil.
Retractable Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.41 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Retractable Technologies (RVP) has a EV-to-FCF of 1.88 as of Jul. 13, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Retractable Technologies and its competitors. According to the industry distribution chart, Retractable Technologies ranks #14 out of 416 companies in the Medical Devices & Instruments industry, placing it in the top 3.4%.
Is Retractable Technologies' EV-to-FCF too high?
Retractable Technologies' current EV-to-FCF is 1.88. The Medical Devices & Instruments industry median EV-to-FCF is 23.36. Retractable Technologies' value of 1.88 is 92% below this industry median. Based on the distribution chart, Retractable Technologies ranks #14 out of 416 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Retractable Technologies has a GF Score™ of 31/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Retractable Technologies' EV-to-FCF compare to ZJYL and HBIO?
According to the Medical Devices & Instruments industry distribution chart, Retractable Technologies ranks #14 out of 416 companies for EV-to-FCF. This places Retractable Technologies in the top 3% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 23.36. Retractable Technologies' value of 1.88 is 92% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.36, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Retractable Technologies's current EV-to-FCF of 1.88 is 92% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Retractable Technologies and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Retractable Technologies's current EV-to-FCF is 1.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Retractable Technologies stock overvalued right now?
Based on GuruFocus' analysis, Retractable Technologies (RVP) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.76, compared to a current price of $0.69 — trading 9.9% below its estimated fair value. The current EV-to-FCF is 1.88 and 92% below the Medical Devices & Instruments industry median of 23.36. Retractable Technologies' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Retractable Technologies (RVP), the current EV-to-FCF is 1.88 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Retractable Technologies (RVP) Overvalued in 2026?
Based on GuruFocus' analysis, Retractable Technologies stock appears to be undervalued.
The current stock price of $0.69 is trading 9.9% below its estimated GF Value™ of $0.76.
GuruFocus considers Retractable Technologies to be Modestly Undervalued.
Key valuation signals for RVP:
EV-to-FCF: 1.88
GF Value™: $0.76 vs. price of $0.69 (9.9% below fair value)
Industry Position: 92% below the Medical Devices & Instruments median (#14 of 416)
No single metric tells the full story. See the RVP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.
31GF Score
Get the complete analysis for RVP
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RVP has been successfully added to your 
